Ummmm ... wow !?

 

This headline really caught my eye.  It's news, but is it newsworthy (like in the big media)? 

New Malaria Antibody Yields Full Protection in Human Trial

"Malaria remains one of the leading causes of death among children in sub-Saharan Africa, claiming more than 600,000 lives each year worldwide with limited efficacy in currently available treatments and vaccines. Now a new early-stage clinical trial found that a novel monoclonal antibody provided dose-dependent full protection against the malaria parasite with minimal side effects.

Researchers at the University of Maryland School of Medicine’s Center for Vaccine Development and Global Health (CVD) conducted the trial in healthy volunteers who were exposed, in a controlled manner, to bites, from mosquitos infected with the malaria parasite."

This is fantastic news. Will the Trump administration allow this research to proceed?

Here's the reference to it.

Lyke KE, Berry AA, Laurens MB, et al. Human monoclonal antibody MAM01 for protection against malaria in adults in the USA: a first-in-human, phase 1, dose-escalation, double-blind, placebo-controlled, adaptive trial. Lancet Infect Dis. 2025:S1473-3099(25)00481-5. doi: 10.1016/S1473-3099(25)00481-5

And here's the enemy.